Open AccessRenal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes
Author(s) -
Michael Mauer,
Bernard Zinman,
Robert Gardiner,
Samy Suissa,
Alan R. Sinaiko,
T. Strand,
Keith Drummond,
Sandra Donnelly,
Paul Goodyer,
MarieClaire Gubler,
Ronald Klein
Publication year - 2009
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa0808400
Subject(s) - medicine , losartan , enalapril , type 2 diabetes , diabetes mellitus , retinal , endocrinology , pharmacology , ophthalmology , renin–angiotensin system , angiotensin converting enzyme , blood pressure
Nephropathy and retinopathy remain important complications of type 1 diabetes. It is unclear whether their progression is slowed by early administration of drugs that block the renin-angiotensin system.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom